Atara Biotherapeutics: Q1 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Atara Biotherapeutics Inc. (ATRA) on Tuesday reported a loss of $78.3 million in its first quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 86 cents.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 93 cents per share.

The drug developer posted revenue of $3.6 million in the period.

Atara Biotherapeutics shares have fallen 31% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $13.61, an increase of 55% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ATRA at